Case Summary:

Some of the key factors in the EB2-NIW (National Interest Waiver) approval of a research data analyst in medical biology from Nepal are:

• As an expert in medical biology, his proposed endeavor was to continue his research using statistical methodologies to design, conduct, and analyze clinical research studies. He wanted to determine better treatment approaches for health disorders, identify adverse health effects of current or past health practices, and find associations and interactions between exposure and existing health treatments.
• His research advancing his proposed endeavor is of great importance because it addresses key medical issues of antibiotic resistance and kidney disease. He has developed methods to improve existing antibiotics’ ability to overcome the resistance of bacteria.
• This research endeavor also has broad implications for the United States where growing antibacterial resistance naturally affects the ability of the United States medical community to treat many common illnesses. He has both improved the ability of antibiotics to overcome antibiotics resistance and identified ways to improve the treatment of patients with kidney disease.
• Due to its clear national importance, his work has been supported with funding from the Veterans Affairs Health Services Research and Development Service.
• His research has also resulted in 4 peer-reviewed journal articles (3 of them first-authored) and 1 peer-reviewed co-authored book chapter and these publications have been cited a total of 80 times according to Google Scholar.
• Many other researchers have been significantly influenced in their own work by his prior findings which illustrate the fact that his case is of great value to the United States.
• Additionally, he has pursued research directly related to his proposed endeavor of using statistical methodologies to design, conduct, and analyze clinical research studies for 10 years.
• His work has been recognized by other experienced researchers who wrote letters recommending his work for the U.S. One of them stated:

“The world is in dire need of new antibiotics or new approaches to treating bacterial infections. [The client], a renowned medical biologist, has conducted highly significant investigations of this problem through a systematic study of antibiotics and bacteria. His research has uncovered new findings regarding the efficacy of existing antibiotics and methods for enhancing their efficacy in treating antibiotic-resistant bacteria.”

These factors went a long way in winning him the approval of the adjudication committee. What is more, his case got expedited approval in just 8 days of application. This was made possible by the premium processing upgrade and our teamwork.

We wish our client all the best in his future endeavors and look forward to seeing his work benefit the U.S. in the future as well.